09:54
The Big Biz Show Interview with Evaxion's CEO Christian Kanstrup
01:33
Inside Evaxion at DTU Science Park
15:36
EvaxMHC 4.0 - A Cutting-Edge AI Building Block
11:42
RAVEN⢠- Model for Uncovering Unique Cross-Protective T-Cell Antigens
15:35
Addressing difficult to treat cancers with AI-Immunologyâ˘
15:04
PIONEER⢠- Validated Model for Designing Personalized Neoantigen Vaccines
14:20
ObsERV⢠- Leading Model for Designing Personalized ERV-Antigen Vaccines
08:50
AI-DEEP⢠- Model for Predicting Responses to Cancer CPI Immunotherapy
19:31
EDEN⢠- Best-in-Class Model Assessing Protectiveness of B-Cell Antigens
13:57
AI-Immunology⢠- A Leading AI Platform
14:14
Evaxion Overview - Setting the Scene
02:09
Evaxion Biotech Announces New Proprietary AI Platform Technology ObsERV
01:53
The vaccine design process at Evaxion
X
About
Evaxion Biotech is an AI-Immunology⢠platform company decoding the human immune system to discover and develop novel immunotherapies for cancer and infectious diseases.
We have developed our AI-immunology core technology to deeply understand the biological processes relevant for engaging the immune system so we can harness its powers through novel immunotherapies. Our scalable AI-immunology core technology enables broad applicability across diseases with immunological components. With deep insights into the biological processes of the immune system, we bridge technology, engineering expertise and drug development know-how to bring novel immunotherapies to patients.
Tags